刘美瑾 医师 Mei-Ching Liu

血液与肿瘤内科部
参与医疗团队: 乳癌团队, 大肠直肠癌团队

专长:

  • 乳房肿瘤

学历:

  • 台大医学院 医学系 医学士 1971.09~1978.06
  • 美国 Sloan Kettering Cancer Center 肿瘤学 研究医师 1986.7~1986.12

 

现职:

 

  • 和信治癌中心医院 血液与肿瘤内科 硕学主治医师 1991.09~迄今

经历:

  • 台大医院 内科 总住院医师及兼任主治医师 1982~2004
  • 台北医学院附设医院 内科 兼任副教授 1991.08~迄今
  • 台北医学院附设医院 内科 部定副教授 1988.01~迄今
  • 台北医学院附设医院 内科 主治医师、讲师 1982.01~1991

专业学会:

  • 中华民国内科医学会
  • 中华民国癌症医学会
  • 中华民国血液病学会
  • 中华民国乳房医学会
  • 台湾癌症安宁缓和医学会
  • 台北巿医师公会

着作:

Invited Speaker

  1. Mei-Ching Liu Taiwan Joint cancer conference A Decade of Docetaxel in the early stage breast cancer, 2006 May.
  2. Mei-Ching Liu The result and experience of BCIRG 006. The Breast Cancer Society of Taiwan. March 2006.
  3. Mei-Ching Liu Margent of TAC in on Asia population. Feb. 2006.
  4. Mei-Ching Liu Target therapy of Breast Cancer. Taiwan Medical Society. Nov. 2005.
  5. Mei-Ching Liu Management of TAC in and Asia population. Chinese Breast Cancer Society. Aug. 2005.
  6. Mei-Ching Liu Management of TAC in an Asia Population. Sanofi-Aventis Asia Oncology Forum.,2005
  7. Mei-Ching Liu Taxotere in Early Breast Cancer. Chinese Oncology Society Taipei May 1, 2004.
  8. Mei-Ching Liu Targeted Therapy for Breast Cancer. Chinese Oncology Society Taipei May 2, 2004.
  9. Mei-Ching Liu Sequential Dose Dense Adjuvant Treatment of A  T  C for Breast Cancer with 10 or more positive nodes. Investigator work shop of Bristol-Myers squib. 2004. Jan. 9 Tailand Bangkok.
  10. Mei-Ching Liu Update the Induction Chemotherapy of Locally Advanced Breast Cancer(LABC)Chinese oncology society, Jul. 26, 2003.
  11. Mei-Ching Liu Breast Cancer in Taiwan in 1st Roche Asia Oncology Forum in Shanghai-China on Sep.20~22, 2002.
  12. Mei-Ching Liu: The Breast Cancer Society of Taiwan:Updates on Post-Operative Adjuvant Chemotherapy for Breast Cancer. “Treatment Options for High-Risk patients” at Taipei, June 8, 2002
  13. Mei-Ching Liu: The Breast Cancer Society of Taiwan:Updates on Post-Operative Adjuvant Chemotherapy for Breast Cancer-“Treatment Options for High-Risk patients” at Kaushung June 9, 2002.
  14. Mei-Ching Liu: Herceptin: the new hope for breast cancer patients. The Annual meeting of radiation oncology in Thailand. Feb. 2001.
  15. Mei-Ching Liu Monoclonal antibody for treatment of metastatic breast cancer. Nov 12, 2001 Taiwan Medical Society.
  16. Mei-Ching Liu : Palliative Respiratory Care Oct, 13 2001. 10th congress of Asia pacific association for respiratory care.
  17. Mei-Ching Liu : Anti-Her gene Treatment for Metastatic Breast Cancer. Sep. 22, 2001. Sino-Japan symposium on cancer treatment.
  18. Mei-Ching Liu : Anti-Her2 gene Treatment for Metastatic Breast Cancer. Chinese Breast Cancer Society Sep. 29, 2001.
  19. Mei-Ching Liu : Concurrent chemoradiation for locally advanced rectal cancer. June 2001, Chinese Society of Digestive disease
  20. Mei-Ching Liu :Target the oncogene in cancer-Herceptin in Launch symposium. Chinese clinical oncology society. Nov. 2000.
  21. Mei-Ching Liu: Adjuvant and induction chemotherapy for breast cancer in SYSCC. Sino-Japan Symposium on Cancer Treatment Oct. 1999.
  22. Mei-Ching Liu, Chii-Ming Chen, Po-Hseng Yang : Multimodality treatment of locally advanced. Breast cancer. The second Terri-Fax breast cancer international symposium, 1997.
  23. Mei-Ching Liu : Multimodality Treatment of locally Advanced Rectal Cancer Chinese Digestive Society. April, 1994.
  24. Mei-Ching Liu, Multimodality treatment of locally advanced rectal cancer, Taiwan Medical Society Nov. 1993.

Publications

  1. Tony MOK, Tsai-Shen YANG, Yee CHAO, Cheng-Hsu WANG, Mei-Ching Lin, Yoon Koo KANG, Won Ki KANG, Jun Suk KIM, Yajie WANG and Thomas LEUNG. Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma.
  2. Li-Jen Kuo, Mei-Ching Liu, James Jer-Min Jian, Cheng-Fang Horng, Tsun-I Cheng, Chung-Ming Chen, Wei-Tse Fang, and Yih-Lin Chung. Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy? Annals of surgical oncology 2007 DOI:10.1245/s10434-007-9471-z
  3. Li-Han Hsu, Thomas C. Soong, An-Chen Feng, MPH, Mei-Ching Liu, Intrapleural Urokinase for the Treatment of Loculated Malignant Pleural Effusions and Trapped Lungs in Medically Inoperable Cancer Patients. Journal of Thoracic Oncology Volume 1, Number 5, June 2006.
  4. Ming-Yuan Lee, Tran-Der Tan, An-Chen Feng, Mei-Ching Liu, Clinicopathological Analysis of malignant Lymphoma in Taiwan, Defined According to the World Health Organization Classification. Haematologica/the hematology Journal, 2005; 90(12) P.1703-1705.
  5. Jason Chia-Hsien Cheng, Mei-Ching Liu, Stella Y. Tsai et al., Unexpectedly Frequent Hepatitis B Reactivation by Chemoradiation in Postgastrectomy Patients. CANCER November 1, 2004/volume101/Number 9 P.2126-2132.
  6. Li-Jen Kuo, Mig-Chih Chern, Mei-Hua Tsou, Mei-Ching Liu, James Jer-Min Jian, Chung-Ming Chen, Yih-Lin Chung, Wei-Tse Fang. Interpretation of Magnetic Resonance Imaging for Locally Advanced Rectal Carcinoma After Preoperative Chemoradiation Therapy. Dis Colon Rectum, January 2005 Vol. 48, No.1 pp23-28
  7. Li-Jen Kuo, Shuh-Yan Leu, Mei-Ching Liu, Chung-Ming Chen. Disseminated Intravascular Coagulation in AStagy IV Colon Patient:Report of A Case and Review of the Literature. Formos JSurg 2003;36:188-192
  8. Li-Jen Kuo, M.D., Shuh-Yan Leu, M.D., Mei-Ching Lin, M.D., James Jer-Min Jian, M.D., Skye Hongiun Cheng, M.D., Chung-Ming Chen, M.D. How Aggressive Should We Be in Patients With Stage IV Colorectal Cancer?Dis Colon Rectum, December 2003 Vol.46, No. 12 p1646-1652.
  9. Jason Chia-Hsien Cheng, Chii-Ming Chen, Mei-Ching Liu, Mei-Hua Tsou, Po-Sheng Yang. Locoregional Failure of Postmastectomy Patients with 1-3 Positive Axillary Lymph Nodes Without Adjuvant Radiotherapy. Int. J. Radiation Oncology Biol. Phys., vol. 52, No. 4, pp. 980-988, 2002.
  10. Cheng-I Hsieh, Mei-Chin Liu, Skye H, Cheng, Tsang-Wu Liu, Chii-Ming Chen, Chris M.C.Chen, Mei-Hua Tsou, and Andrew T. Huang, M.D.: Adjuvant Sequential Chemotherapy With Doxorubicin Plus Cyclophosphamide, Methotrexate, and Fluorouracil (ACMF) With Concurrent Radiotherapy in Resectable Advanced Breast Cancer. Am J. Clin Oncol(CCT)23(2):122-127, 2000. (SCI)
  11. You DL, Liu MC, Tai YC, Tsou, MH : Gallium 67 scan in granulocytic sarcoma Ann. Nu Med Sci,. 14:125~128, 2001. .
  12. S.K. Cheng, M.H. Tsou. M.C. Liu et. al.: Clnique Features of Breast Cancer in Taiwan Breast Cancer Research and Treatment J. Cancer and Treatment 63:213-223 2000.
  13. Jason Chia-H Sien Cheng, Chii Ming Chen, Mei-Ching Liu Locoregional Recurrence in Patients with One to Three Positive Axillary Nodes after Mastectomy Without Adjuvant Radiotherapy J. Formosa Med Assoc, 2000 Vol 99 No 10. .(SCI)
  14. Cheng SH, Chen CM, Liu MC, Huang AT. Clinical Practice Guidelines for Breast Cancer. J. Chinese Oncol. Soc 1999; 15:12~28.
  15. 15. SH Cheng, Jian JM, Chen KY, YU Tsaiyc, Liu MC, Chen CM: The Benefit and risk of postmastertomy radiation therapy in high risk breast cancer. Am J. clin oncol 21(1):12-17, 1998(SCI)..
  16.  Ch'ang HJ, Jian JM, Cheng SH, Liu MC, Leu SY, Wang KY, Tsai SYC, Tsao MH, Lin HH, Huang AT. Sung JL. Preoperative Concurrent Chemotherapy and Radiotherapy in Rectal Cancer Patients. J. Formos Med Assoc. 97(1): 32-37, 1998.
  17. Cheng SH, Liu TW, Jian JM, Tsai SYC, Hao SP, Huang CH, Liu MC, Ben Yu, Huang AT. Concomitant Chemotherapy and Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma. Cancer J Sci Am 3(2): 100-106, 1997.
  18. Ch’ang’ HJ, Cheng SH, Liu MC, Jian JM, Chen CM. Postoperative Concurrent Chemotherapy and Radiotherapy for Resectable Locally Advanced Gastric Cancer Patients. A Preliminary Report. Therapeut Radiol Oncol 4: 195-201, 1997.
  19. 陈荣邦, 郑鸿钧, 詹光裕, 刘美瑾: 磁振造影对评估食道癌肿瘤范围的前瞻性研究。台湾医界40卷第2期10-12页, 1997年。
  20. Cheng SH, Chen CM, Jian JM, Tsai SYC, Liu TW, Liu MC, Chen MC, Lin HH. Breast-Conserving Surgery and Radiotherapy for Early Breast Cancer. J Formosa Med Assoc 95:372-7, 1996.
  21. Cheng SH, Chan WP, Lin YM, Liu MC, Chan KY, Jian JM. Magnetic Resonance Imaging in the Determination of Radiation Treatment Volume in Esophageal Carcinoma. J. Chinese Oncol. Soc. 11: 25-32, 1995.
  22. Liu MC, Hai A, Huang AT. Cancer and Epidemiology in the Far East: Contrast with the United States. Oncology Vol 7, No. 6, June 1993: 99-110.
  23. Liu MC, Chen YC, Tsay Woei, Shen MC, Wang CH, Liu CH. Treatment of refractory acute leukemia with high-dose cytosine arabinoside (Ara-C). J. Formosan Med Assoc 1987; 86:628-633.
  24. Liu MC, Chen YC, Lee TK. Studies of platelet hyperactivity in patients with ischemic crebrovascular diseases. III. Platelet hyperactivation in chronic phase of cerebral thrombomebolism. J. Formosan Med Assoc 1985; 84:468-473
  25. Liu MC. Immunomodulatory therapy of aplastic anemia. J. Formosan Med Assoc 1989; 88 (suppl 3): 390-395.
  26. Skye H. Cheng, Chii-Ming Chen, James J. Jian, Stella Y. Tsai, Walter Tsang-Wu Liu, Mei-Chin Liu, Chris Min-Chun Chen and Hshu-Hshing Lin : Breast-Conserving Surgery and Radiotherapy for Early Breast Cancer, J Formos Med Assoc 1996, Vol 95, No 5:p372-7.
  27. Yen ML, Chen YC, Lin MT, Liu MC, Tang JL, Wang CH, Hsieh CY : High dose chemotherapy with support by autologous bone marrow and GM/CSF in the treatment of advanced ovarian cancer: preliminary report of a new strategy. Transplantation Proceedings, 1992;24:1533-5.
  28. Tang JL, Lin MT, Liu MC, Wang CH, Lui LT, Chen YC. Successful reinduction of remission with low-dose ARA-C in a patient with myelodysplastic syndrome relapsed after allogeneic bone marrow transplantation: restoration of donor hematopoiesis detectd by amplification of minisatellite genes. Transplantation Proceedings, Vol 24, No 4 (August),1992 : pp 1522-1523.
  29. Lin MT, Chen YC, Liu TW, Tien HF, Liu MC, Wang CH, Shen MC, Liu CH. Treatment of refractory or relapsed adult acute leukemia by using mitoxantrone-containing regimens. J. Formosan Med Assoc 1989; 88:1116-1122.
  30. Lee TK, Chen YC, Kuo TL, Lien IN, Liu MC, Huang ZS. Effect of low dose acetylsalicylic acid upon plasma thromboxane B2 levels and platelet aggregation in ischemic stroke patients. Clinical Chimica Acta 1989; 184:323-328.
  31. Cheng AL, Su IJ, Chen YC, Wang CH, Hsieh HC, Chen CL, Tien HF, Liu MC, Lai HS, Liu TW, Shiau PC, Shen MC, Liu CH: Adult non-Hodgkin's lymphoma in Taiwan area - a clinicopathological study of 123 cases by using working formulation classification J Formosan Med Assoc 1989; 88:108-113.
  32. Lai HS, Tien HF, Hsieh HC, Chen YC, Su IJ, Wang CH, Liu MC, Cheng AL, Shen MC, Liu CH. Bone Marrow Involvement in non-Hodgkin's lymphoma. J. Formosan Med Assoc 1989; 88:114-121.
  33. Lee TK, Chen YC, Lien IN, Liu MC, Huang ZS. Inhibitory effect of various doses of acetylsalicylic acid no platelet function in patients with completed stroke or reversible ischemic neurological deficit. Stroke 1988; 19:566-570.
  34. Chen YC, Liu MC, Wang CH. Studies of PGI2 degradation in patients with quantitative platelet disorders. Prostagle Leuk and Essential Fatty Acid 1987; 32:39-43.
  35. Chen YC, Sun HI, Lin DT, Liu MC, Yang YC, Wang CH, Wu MC Assay of hemopoietic stem cell activities in peripheral blood of patients with acute leukemia. J. Chinese Oncol Soc 1987; 3:19-24.
  36. Chen YC, Kuo TL, Liu MC, Lien IN, Ang A, Lee T-K. Studies of platelet hyperactivity in patients with ischemic cere brovascular diseases. IV. effects of various doses of aspirin - determination of the optimal dose. J. Formosan Med Assoc 1987; 86:923-931.
  37. Chen YC, Wang CH, Lin DT, Lui PT, Cheng AL, Lin TW, Tsay Woei, Tien HF, Liu MC, Chun WM, Lee LN, Su IJ, Hsieh RP, Shen MC Liu CH, Lin KS. Allogeneic bone marrow transplantation in the treatment of leukemia - a preliminary report. J. Formosan Med Assoc 1987; 86:490-496. (Chinese).
  38. Chen YC, Sun HI, Lin DT, Liu MC, Yang YC, Wang CH, Wu MC. Assay of hemopoietic stem cell activities in periphera blood of patients with acute leukemia. J. Chinese Oncol Soc 1987; 3:19-24. (Chinese).
  39. Lee WJ, Liaw KY, Chen KM, Liu MC, Chen YC, Wang CH, Shen MS, Liu CH, Lin KS. Therapeutic splenectomy for hematological diseases. J. Formosan Med Assoc 1987; 86:152-157.
  40. Uen WC, Liu MC, Wang CH, Tien HF, Chen YC, Shen MC, Liu CH. Myelodysplastic syndrome - clinical analysis of 16 cases. J. Formosan Med Assoc 1986; 85:596-607.
  41. Chen YC, Lee TK, Hsu KL, Liu MC, Lien IN. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases. I. Changes of platelet aggregation-emphasis on hypoaggregation in vitro secondary to hyperactivation in vivo. J Formosan Med Assoc 1985; 84:339-347.
  42. Cheng AL, Chen YC, Wang CH, Shen MC, Hsieh RP, Tien HF, Liu MC, Lai HS, Liu CH. Adult acute lymphoblastic leukemia. J. Formosan Med Assoc 1986; 85:973-983.
  43. Chen YC, Wang CH, Huang SC, Lee EF, Lin DT, Shen MC,Liu MC, Tien HF, Lin KS. Autologous bone marrow transplantation after superlethal dose of total body irradiation in a case of mycosis fungoides. J. Formosan Med Assoc 1986; 85:304-314.
  44. Liu MC, Chen YC, Lee TK. Studies of platelet hyperactivity in patients with ischemic crebrovascular diseases. III. platelet hyperactivation in chronic phase of cerebral thrombomebolism. J. Formosan Med Assoc 1985; 84:468-473.
  45. Chen YC, Wang CH, Liu MC, Lee SY, Lu YC, How SW. Pre-suppressor T-cell lymphoma with borderline hypogamanaglobulinemia. International Hematology Congress, Buda-Pest. August 1982. pp. 168 (abstract).

Conference Paper.

  1. Mei-Ching Liu, C.M. Chen, .P.H. Yang, B. L. Yu, Sequential Dose Dense Usage of Adriamycin, Taxol, High Dose Cyclophosphamide with G-CSF Support Improved the Survival of Breast Cancer with Ten or more Positive Lymphnodes than A-CMF Regimen. 4th European Breast Cancer Conference 16-20 March, 2004.
  2. Mei-Ching Liu, Y.M. Lin, M.Y. Lee The Possible Life-threatening Reactivation of Hepatitis B During Chemotherapy Can be Prevented by a Close Monitor of Liver Function During Chemotherapy. 4th European Breast Cancer Conference 16-20 March, 2004.
  3. Mei-Ching Liu, C.M. Chin, B. L. Yu. The Induction Chemotherapy with Taxotere and Cisplatin for Locally Advanced Breast Cancer. 4th European Breast Cancer Conference 16-20 March, 2004.
  4. Mei-Ching Liu, Wei-Tse Fang, Nei-Min Chu, Cheng-I Hsieh, Combination Treatment of Herceptin with Chemotherapy for Metastatic Breast Cancer. Chinese oncology society, Jul. 26, 2003.
  5. Tran-Der Tan, Mei-Ching Liu, Andrew T. Huang. Engraftment Syndrome following Hematopoietic Stem Cell Transplantation. Chinese oncology society, Jul. 26, 2003.
  6. Chi-Feng Chung, Mei-Ching Liu, Chiang-Ching Shih. Pseudomonas aeruginosa Bacteremia in Patients with Cancer. Chinese oncology society, Jul. 26, 2003.
  7. Lin-Chieh Huang, Mei-Ching Liu, James Jer-Min Jian, Andrew T. Huang Multidisciplinary Therapy For Anal Cancer. Chinese oncology society, Jul. 26, 2003.
  8. Ming-Hsien Lin, Wei-Tse Fang, Mei-Ching Liu, Mei-Hua Tsou, Ming-Yuan Lee, Jeffrey C. Chen, Ya-Ling Hsu, Andrew T. Huang Hypoglycemia Caused by an Atypical Carcinoid Tumor of the Uterine Cervix. Chinese oncology society, Jul. 26, 2003.
  9. Souyi Chang, Shu-Jen Chang, Lien-Yen Young, Mei-ching Liu. Preliminary report of post-operation adjuvant chemotherapy for urinary tract transitional cell carcinoma at SYSCC. Chinese oncology society, Jul. 26, 2003.
  10. Hsin-Hsuan Chen, Kwan-Yee Chan, Skye Hongiun Cheng, Lawrence Kai-Cheng Yen, Mei-Ching Liu. New concept of T stage of nasopharyngeal carcinoma. Chinese oncology society, Jul. 26, 2003.
  11. Mei-Ching Liu; Skye Hongiun Cheng; Shuh-Yan Leu et al : Preoperative 5FU and Mitomycin-C with Concomitant Radiotherapy for Locally Advanced Rectal Cancer. Chinese Cancer Society, May 4. 2002.
  12. Mei-Ching Liu, Andrew T. Hwang, Chrisopher K.J. Lin et al : Histologically and Serologically Proven Viral Hepatitis B Reactivation During Chemotherapy for Breast Cancer. Chinese Cancer Society, May 4. 2002.
  13. Mei-Ching Liu, Wei-Tse Fang, Po-Hseng Yang et al : Postoperative Adjuvant Chemoradiation for Resectable Gastric Cancer. Chinese Cancer Society, May 4. 2002.
  14. Preoperative 5FU Mitomycin C concomitant with radiation for locally advanced rectal cancer. European Cancer. Conference Oct. 2001.
  15. Mei-Ching Liu, Chii-Ming Chen, Po-Hseng Yang et al : Sequential dose Intensity usage of Adriamycin Taxol and High dose cyclophosphamide with G-CSF support for breast cancer with ten or more lymph nodes 5th International conference of the Asian clinical oncology society. April 5-8, 2001.
  16. Mei-Ching Liu, Chii-Ming Chen, Po-Hseng Yang : Multimodality treatment of locally advanced,. Breast cancer. 5th International conference the Asian clinical oncology society April 5-8, 2001.
  17. Mei-Ching Liu, Chii-Ming Chen, Po-Hseng Yang et al : Sequential dose Intensity usage of Adriamycin Taxol and High dose cyclophosphamide with G-CSF support for breast cancer with ten or more lymph nodes Taipei. International breast cancer symposium Oct, 2000.
  18. Mei-Ching Liu, Chii-Ming Chen, Po-Hseng Yang : Multimodality treatment of locally advanced. Breast cancer. Taipei. International breast cancer symposium. Oct 2000.
  19. James J Jian, Skye H Cheng, Huang CH, Liu TW, Liu MC : Improved local control of nasopharyngeal carcinoma aided by computerized tomography treatment planning. The Radiological Society of the R.O.C. April, 1993; F339B.
  20. Skye H Cheng, James J Jian, Liu TW, Liu MC, Huang CH: Preliminary experiences of concurrent chemotherapy and radiation therapy in locally advanced nasopharyngeal carcinoma. The Radiological Society of the R.O.C. April, 1993; F340B.
  21. Liu MC, Liu TW, Wang FM, James J Jian, Skye H Cheng, Andrew T Huang: Preliminary experiences of multidisciplinary treatment of locally advanced rectal cancer. Chinese Oncology Society April, 1993.
  22. Kok CK, Liu TW, Liu MC, Lin HH, Ou Honzen, Skye H Cheng: Microangiopathic thrombocytopenia and hemolytic anemia in metastatic epithelioid angiosarcoma-Case report. Chinese Oncology Society April, 1993.
  23. HL. Amplification of leukemic blasts in marrow culture system to detect early relapse of acute lymphoblastic leukemia. Exp. Hematol 17: 662, 1989 (abstract). The 18th Annual Meeting of International Society for Experimental Hematology 16- 20 July, 1989, Paris, France.
  24. Cheng AL, Wang CH, Su IJ, Tien HF, Liu MC, Liu TW, Hsieh RP, Chen YC: Cyclosporine - induced hematological recovery in aplastic anemia - possible linkage with increased natural killer cells and monocyte activity. Experimental Hematology 1987; 15:554.
  25. Chen YC, Liu MC, Kuo LL, Wang CH, Yang PM. Increased plasma 6-keto-PGFI2 in veno-occlusive disease of the liver following bone marrow transplantation. Exp Hematol 14: 529, 1986. (Abstract).
  26. Chen YC, Liu MC, Kuo LL, Wang CH. PGI2 degradation in quantitative platelet disorders. Book of abstract, XXI Congress of the International Society of Hematology and XIX Congress of the International Society of Blood Transfusion, p. 412, 1986.
  27. Uen WC, Wang CH, Liu MC, Chen YC, Tien HF, Shen MC, Liu CH, Myelodysplastic syndrome - clinical analysis of 16 cases. Tr. HSROC, p. 25, 1986.
  28. Chen YC, Lin DT, Wang CH, Shen MC, Der Rai, Liu MC, Tien HF, Liu CH, Lin KT Bone marrow transplantation in NTUH. Tr. HSROC, p. 4-5, C1986.
  29. Chen YC Wang CH, Wu KD, Der Rai, Huang SJ, Liaw KY, Won YN, Shen MC, Tien HF, Liu MC, Lin DT, Lin KT, Allogenic bone marrow transplantation in a case of CML -preliminary report. Tr. HSROC, p. 7-8, 1985.
  30. Liu MC, Chen YC, Lee TK, Lien IN. Effect of daily 300 mg aspirin on the production of thromboxane A2 and prostacyclin in patients with cerebral stroke. 6th Asian and Oceanian Congress of Neurology, Taipei, November 13-17, p. 122, 1983.(Abstract).
  31. Liu MC, Young PS, Shen MC, Wang CH, Chen YC, Has HG, Angioimmunoblastic lymphadenopathy - experience in NTUH. Tr. HSROC, p. 31, 1983.
  32. Chen YC, Liu MC, Wang CH, Lee CY, Leu YC, Has HG, A case of T-cell lymphoma with suppressor cell phenotype. Tr. HSROC, P. 109-110, 1982.

Principle Investigator of Clinical Trials

  1. Phase III randomized, multi center study of Sunitinib malate (SU011248) or Capectitabine in subjects with advanced breast cancer who failed both a taxane and anthracyline chemotherapy regimen or failed with a taxane and for whom futher anthracycline therapy is not indicated.
  2. 比较口服Vinorabine + Capecitabine与连续口服Vinorabine跟随Capecitabine与Docetaxel + Capecitabine 三种化学治疗法用於先前使用过anthracyclines治疗的转移性乳癌病患之随机分配第二期临床试验, 2006.
  3. A randomized, open –label ,multicenter ,phase III study of Epoetin Alfa plus standard supportive care versus standard. Supportive care in anemic patients with metastic breast cancer receiving first –line standard chemotherapy, 2006.
  4. 开放标示、对照、随机分配、多中心之第三期临床试验:比较5-FU/FA/irinotecan并用cetuximab 与 5-FU/FA/irinotecan作为EGFR阳性反应之转移性大肠直肠癌患者第一线治疗之疗效与安全性, 2005.
  5. A randomized, open-label,phaseIII study of RPR109881 IV every 3 weeks versus capecitabine (Xeloda ) tablets twice daily for 2 weeks cycle in patients with metastasis breast cancer progressing after taxanes and anthracycline therapy
  6. A phase III trail of Novel Epothilone BMS-247550 plus Capecitabine versus Capectitabine alone in patients with advanced breast cancer previously treated with an Anthracycline and a Taxane
  7.  BCIRG 005 A Multicenter Phase III Randomized Trial Comparing Docetaxel In Combination With Doxourbicin And Cyclophosphamide (TAC) Versus Doxorubicin And Cyclophosphamide Followed By Docetaxel (AC  T) As Adjuvant Treatment Of Operable Breast Cancer Her2neu Negative Patients With Positive Axillary Lymph Nodes
  8. BCIRG 006 Multicenter Phase III Randomized Trial Comparing Doxorubicin And Cyclophosphamide Followed By Docetaxel (Ac  T) With Doxorubicin And Cyclophosphamide Followed By Doxctaxel And Trastuzumab(TCH)In The Adjuvant Treatment Of Node Positive And High Rick Node Negative Patients With Operable Breast Cancer 10ntaining The Her2 Alteration.
  9. An Open Non-Comparative Efficy And Safety Study To Evaluate Arimidex In Post-Menopausal Women With Advanced Breast CancerSponsor : Zeneca Pharma International, 1997-05 To 1998-11
  10. A Phase II Study Of Docetaxel In The Treatment Of Patients With Advanced Or Metastatic Breast Cancer Sponsor : Rhone-Poulenc Rorer Recherche-Developpement, 1996-01 ~ 1997.06
  11. An open label randomized phase III study of intermittent oral capecitabine in combination with intravenous Oxaliplatin (Q3W) (XELOX)versus Fluorouracil / Leucovorin as adjuvant therapy for patients who have undergone surgery for colon carcinoma , AJCC/UICC stage III (Dukes stage C) 2004.03
  12. Rp6414-307 Multicentrre Phase III Open Label Randomised Trial Comparing Cpt-11 Combination With A 5-Fu/Fa Infusional Regimen To The Same 5-Fu/Fa Infusional Regimen Alone As Adjuvant Treatment Of Stage III Colon Cancer 2001.09~2002.03.
  13. CRC-200301 A randomized,double–blind,placebo-controlled,phase IIIstudy in patients with metastatic adenocarcinoma of the colon or rectum who are receiving first-line chemotherapy with Oxaliplatin 5-Fluorouracil /Leucovorin and PTK787/ZK222584 or placebo. 2003.09
  14. Preoperative Concurrent Chemo Radiation Of Locally advanced Rectal Cancer Since 1992~1999.
  15. An open label phase IIa trial evaluating the safety and efficacy of EPO906 as therapy in patients with advanced local or metastatic gastric cancer. 2003.09
  16. Postoperative Concurrent Chemo Radiation For Operable Gastric Cancer Since 1993-1999
  17. HCC-200201 A phase II study of efficacy and safety of irinotecan (Campto®)in combination with capecitabine (Xeloda®)as first-line chemotherapy in the Asia subjects with inoperable hepatocellular carcinoma. 2002.11
  18. A Phase II/III ,Radomized,Controlled Study Of Thymitaq Versus Doxorubinic In Patients Having Hepatocellular Carcinoma Sponsor : Agouron Pharmaceuticals, Inc.1997-03 1997-12 Closed
  19. Phase II Study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2009; 5: 95-100. Tony MOK, Tsai-Shen YANG, Yee CHAO, Cheng-Hsu WANG, Mei-Ching LIU, Yoon Koo KANG, Won Ki KANG, Jun Suk KIM, Yajie WANG and Thomas LEUNG.
     
TOP
Copyright © 医疗财团法人辜公亮基金会和信治癌中心医院 台湾 台北市北投区立德路125号 电话:(02) 2897-0011 / (02) 6603-0011